Evaluation of morbidity among human T lymphotropic virus type I carriers in Miyazaki, Japan

被引:27
作者
Stuver, SO [1 ]
Tachibana, N [1 ]
Okayama, A [1 ]
Mueller, NE [1 ]
机构
[1] MIYAZAKI MED COLL,DEPT MED 2,KIYOTAKE,JAPAN
关键词
D O I
10.1093/infdis/173.3.584
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Morbidity associated with human T lymphotropic virus type I (HTLV-I) infection was investigated in a Japanese population within an area in which HTLV-I infection is endemic. Of 1824 subjects enrolled in the Miyazaki Cohort Study between November 1984 and May 1991, 500 (27.4%) were seropositive for HTLV-I antibodies, As expected from previous studies, HTLV-I positivity appeared to be associated with baseline history of anemia (adjusted odds ratio [OR] = 1.3; 95% confidence interval [CI] = 0.99-1.7) and kidney disease (OR = 1.6; 95% CI = 0.91-2.9); a positive association also was noted for asthma in men (OR = 3.4; 95% CI = 1.2-9.8), Unanticipated findings included a relationship between HTLV-I infection and cardiac disease history (OR = 1.4; 95% CI = 0.94-2.2); HTLV-I carriers also were more likely to have an abnormal electrocardiogram at baseline (OR = 1.5; 95% CI = 1.2-1.9), Furthermore, an apparent protective effect for ulcers (OR = 0.62; 95% CI = 0.40-0.95) and diabetes (OR = 0.49; 95% CI = 0.22-1.1) was observed, HTLV-I infection may modify the risk of specific disease outcomes by altering host immune function.
引用
收藏
页码:584 / 591
页数:8
相关论文
共 54 条
  • [21] LERNMARK A, 1985, COMP TYPE 1 TYPE 2 D, P107
  • [22] PREVALENCE OF POSSIBLE ADULT T-CELL LEUKEMIA VIRUS-CARRIERS AMONG VOLUNTEER BLOOD-DONORS IN JAPAN - A NATION-WIDE STUDY
    MAEDA, Y
    FURUKAWA, M
    TAKEHARA, Y
    YOSHIMURA, K
    MIYAMOTO, K
    MATSUURA, T
    MORISHIMA, Y
    TAJIMA, K
    OKOCHI, K
    HINUMA, Y
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (06) : 717 - 720
  • [23] HTLV-I-ASSOCIATED B-CELL CLL - INDIRECT ROLE FOR RETROVIRUS IN LEUKEMOGENESIS
    MANN, DL
    DESANTIS, P
    PFEIFER, A
    NEWMAN, M
    GIBBS, N
    POPOVIC, M
    SARNGADHARAN, MG
    GALLO, RC
    CLARK, J
    BLATTNER, W
    [J]. SCIENCE, 1987, 236 (4805) : 1103 - 1106
  • [24] ROLE OF HTLV-I IN DEVELOPMENT OF NON-HODGKIN-LYMPHOMA IN JAMAICA AND TRINIDAD-AND-TOBAGO
    MANNS, A
    CLEGHORN, FR
    FALK, R
    HANCHARD, B
    JAFFE, ES
    BARTHOLOMEW, C
    HARTGE, P
    BENICHOU, J
    BLATTNER, WA
    [J]. LANCET, 1993, 342 (8885) : 1447 - 1450
  • [25] DISEASES AMONG MEN LIVING IN HUMAN T-LYMPHOTROPIC VIRUS TYPE-I ENDEMIC AREAS IN JAPAN
    MATSUZAKI, T
    OTOSE, H
    HASHIMOTO, K
    SHIBATA, Y
    ARIMURA, K
    OSAME, M
    [J]. INTERNAL MEDICINE, 1993, 32 (08) : 623 - 628
  • [26] ETHNIC-COMPOSITION, AGE AND SEX, TOGETHER WITH LOCATION AND STANDARD OF HOUSING AS DETERMINANTS OF HLTV-I INFECTION IN AN URBAN TRINIDADIAN COMMUNITY
    MILLER, GJ
    PEGRAM, SM
    KIRKWOOD, BR
    BECKLES, GLA
    BYAM, NTA
    CLAYDEN, SA
    KINLEN, LJ
    CHAN, LC
    CARSON, DC
    GREAVES, MF
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (06) : 801 - 808
  • [27] MIYAZAKI K, 1991, OBSTET GYNECOL, V77, P107
  • [28] HTLV-I UVEITIS - A DISTINCT CLINICAL ENTITY CAUSED BY HTLV-I
    MOCHIZUKI, M
    WATANABE, T
    YAMAGUCHI, K
    TAKATSUKI, K
    YOSHIMURA, K
    SHIRAO, M
    NAKASHIMA, S
    MORI, S
    ARAKI, S
    MIYATA, N
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (03): : 236 - 239
  • [29] MORGAN OS, 1989, LANCET, V2, P1184
  • [30] THE EPIDEMIOLOGY OF HTLV-I INFECTION
    MUELLER, N
    [J]. CANCER CAUSES & CONTROL, 1991, 2 (01) : 37 - 52